当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Youyou Tu and Alan Turing*
The majority of ailments are related with adjustments in more than one molecular pathways and complicated interactions at the cell and organ levels. Single-target monotherapies consequently have intrinsic barriers with admire to their most therapeutic benefits. The manageable of aggregate drug healing procedures has acquired pastime for the therapy of many illnesses and is properly installed in some areas, such as oncology. Combination drug redress may additionally permit us to discover synergistic drug effects, decrease negative drug reactions, and tackle variability in sickness traits between patients. Identification of aggregate remedies stays challenging. We talk about modern-day today’s structures pharmacology tactics to allow rational identification of mixture therapies. These approaches, which consist of characterization of mechanisms of sickness and drug motion at a structures level, can allow grasp of drug interactions at the molecular, cellular, physiological, and organismal levels. Such multiscale appreciation can allow precision remedy by using merchandising the rational improvement of mixture remedy at the stage of person sufferers for many diseases.